TY  - JOUR
AU  - Santin, M.
AU  - Morandeira-Rego, F.
AU  - Alcaide, F.
AU  - Rabunal, R.
AU  - Anibarro, L.
AU  - Aguero-Balbin, R.
AU  - Casas-Garcia, X.
AU  - Perez-Escolano, E.
AU  - Navarro, M. D.
AU  - Sanchez, F.
AU  - Coira-Nieto, A.
AU  - Trigo-Daporta, M.
AU  - Martinez-Menaca, A.
AU  - Gonzalez-Cuevas, A.
AU  - Lopez-Prieto, M. D.
AU  - Dominguez-Castellano, A.
AU  - Jove, N.
AU  - IL-2 Study Team
PY  - 2016
DO  - 10.1016/j.cmi.2016.09.004
SN  - 1198-743X
UR  - http://hdl.handle.net/10668/18751
T2  - Clinical microbiology and infection
AB  - Objective: Previous reports have identified interleukin-2 (IL-2), quantified in the supernatants of QuantiFERON (R)-TB Gold In-tube (QFT) after 72 h of incubation, as a potential biomarker for distinguishing between latent and active tuberculosis...
LA  - en
PB  - Elsevier sci ltd
KW  - Active tuberculosis
KW  - Interferon-gamma
KW  - Interleukin-2
KW  - Latent tuberculosis infection
KW  - QuantiFERON
KW  - Memory
KW  - Cells
TI  - Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study
TY  - research article
VL  - 22
ER  -